SCHEMBL6071998

SCHEMBL6071998

N#Cc1c(N)nc2ccccc2c1CCN1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.51
GAA P10253 6/20 0.51
KDM4E B2RXH2 6/20 0.51
GLA P06280 5/20 0.51
HPGD P15428 5/20 0.51
HSD17B10 Q99714 5/20 0.51
CASP1 P29466 3/20 0.51
CASP7 P55210 2/20 0.51
POLB P06746 3/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48
RAD52 P43351 1/20 0.48
RAB9A P51151 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
ADORA2A P29274 1/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071664 0.86 NCF1 (0.41) ALDH1A1GAAKDM4EGLAHPGD
SCHEMBL6071754 0.79 ADORA2A (0.44) ALDH1A1GAAKDM4EGLAHPGD
SCHEMBL6071752 0.77 ALDH1A1 (0.54) ALDH1A1GAAKDM4EGLAHPGD
SCHEMBL6071945 0.76 ALDH1A1 (0.49) ALDH1A1GAAKDM4EHSD17B10KMT2A
SCHEMBL6071926 0.74 ALDH1A1 (0.46) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL28048692 0.73 NCF1 (0.59) ALDH1A1GAAKDM4EGLAHPGD
SCHEMBL6265005 0.73 TLR8 (0.64) ALDH1A1GAAKDM4EGLAHPGD
SCHEMBL6071996 0.72 ADORA2A (0.46) ALDH1A1GAAKDM4EGLAHPGD
SCHEMBL6072069 0.72 KDM4E (0.50) ALDH1A1GAAKDM4EGLAHPGD
SCHEMBL16833150 0.69 ALDH1A1 (0.48) ALDH1A1GAAKDM4EGLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same WYETH (US) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same TNNI3K, CSNK1A1L, CDKL1 ALDH1A1 3975/4885GAA 4325/4885KDM4E 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.